found that USP39 enhances HMGA2 expression in high-grade serous ovarian cancer (HGSOC) by facilitating the efficient splicing of HMGA2, thereby indirectly contributing to tumor progression (42). Here, HMGA2 is linked to ovarian serous adenocarcinoma.